We are live on ! Find out more
AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
1-Year Est. Return 58.35%
This Fund
S&P 500
This Quarter Est. Return
+12.07%
1 Year Est. Return
-58.35%
3 Year Est. Return
-89.8%
5 Year Est. Return
-87.69%
10 Year Est. Return
AUM
$62.3M
AUM Growth
+$9.79M
Cap. Flow
+$3.03M
Cap. Flow %
4.86%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
SNAP icon
Snap
SNAP
+$3.03M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.72%
2 Communication Services 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTLA icon
1
Intellia Therapeutics
NTLA
$1.5B
$59.7M 95.72%
3,729,788
SNAP icon
2
Snap
SNAP
$7.32B
$2.67M 4.28%
+150,160
New +$3.03M

Similar funds

Atlas Venture Associates IX's Q2 2017 Portfolio in Review

As of Q2 2017, Atlas Venture Associates IX held 2 positions worth $62.3M, up 19% from $52.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Atlas Venture Associates IX deployed $3.03M of net new capital in Q2 2017, opening 1 new position. Its largest new stake was Snap: 150,160 shares worth $2.67M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 100% a quarter earlier, followed by Communication Services.

  • Atlas Venture Associates IX's largest Q2 2017 buy was Snap: 150,160 shares worth $2.67M.
  • Atlas Venture Associates IX's ten largest holdings make up 100% of its $62.3M portfolio in Q2 2017.
  • Atlas Venture Associates IX opened 1 new position and closed 0 in Q2 2017.
  • Atlas Venture Associates IX's portfolio value rose 19% quarter-over-quarter to $62.3M.

Based on Atlas Venture Associates IX's 13F filing for Q2 2017, filed 18 Jul 2017.